Post Tagged with: "OTCQB:BCLI"

BrainStorm Cell Therapeutics (OTCQB:BCLI): To Present at Multiple Conferences

BrainStorm Cell Therapeutics (OTCQB:BCLI): To Present at Multiple Conferences

OTC News October 8, 2013 at 12:10 pm 0 comments

Today on Tuesday, October 08, 2013 BrainStorm Cell Therapeutics (OTCQB: BCLI) announced that the company will be presenting at multiple scientific conferences during this month and provided the brief about such conferences which include the following: 5th International Stem Cell Meeting, Israel Stem Cell Society BrainStorm’s Chief Scientific Advisor, Professor DaniOffen, will presentat the 5th International Stem Cell Meeting duringRead More

BrainStorm Cell Therapeutics (OTCQB:BCLI): Initiates US Activities for ALS Clinical Trial

BrainStorm Cell Therapeutics (OTCQB:BCLI): Initiates US Activities for ALS Clinical Trial

OTC News October 1, 2013 at 6:32 pm 0 comments

BrainStorm Cell Therapeutics (OTCQB:BCLI) on Tuesday, October 01, 2013 announced that it has initiated activities in the United States towards preparation for its Phase IIa multi-center clinical study. This includes initiation of the technology transfer process of the company’s proprietary NurOwn to the DFCI (Dana Farber Cancer Institute). Connell and O’Reilly Cell Manipulation Core Facility at DFCI will then engageRead More